Each one in plain English, with the numbers worked through for a shareholder.
14 July 2025capital raising announcement▲ GoodMajor
The Share Purchase Plan closed having raised the A$4M target through about 9.1M shares at 44c, after about A$10M of applications were received and scaled back. This completes the June raising; cash is over A$85M.
What it means for a shareholder
9.1m new shares at $0.440 to raise about $4.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
The Share Purchase Plan, which was due to close 11 July, is closing early on 9 July because applications exceeded the A$4M target. Applications will be scaled back.
Offer letter for the Share Purchase Plan: eligible Australian and New Zealand holders can buy A$2,500 to A$30,000 of shares at 44c, aiming for up to A$4M. Closes 11 July 2025; the board may scale back applications.
18 June 2025capital raising announcement▲ GoodMajor
Turaco raises about A$60M at 44c per share, a 9.3% discount, with bids well above the size sought. Pro forma cash is over A$83M, and a Share Purchase Plan of up to A$4M at the same price is planned. Funds go to drilling and feasibility work.
18 Oct 2024capital raising announcement▲ GoodMajor
Turaco raised A$35M at 31c per share (about 112.9M shares), a 13.9% discount to the last price. Pro forma cash is over A$48M, funding faster Afema drilling; an updated resource is targeted for Q1 2025. A second tranche needs shareholder approval.
What it means for a shareholder
113m new shares at about A$0.310 to raise about A$35.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Placement of 112.5M shares at 16c raised A$18M, a 5.9% discount to the last trade of 17c. It was overbid more than two times, with proceeds to accelerate Afema drilling toward a maiden resource. It follows the A$6.6M raising at 9c in November 2023.
What it means for a shareholder
113m new shares at $0.160 to raise about $18.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
29 Nov 2023capital raising announcement▲ GoodMajor
Placement of 73.3M shares at 9c raised A$6.6M, a 14% discount to the last trade, plus A$80,000 of director participation subject to approval. Funds the US$1.5M Afema payment and drilling. Resolves the funding need after the Afema deal; existing 11.15M performance rights were also exercised.
What it means for a shareholder
73.3m new shares at $0.090 to raise about $6.6m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
11 May 2023capital raising announcement▲ GoodMajor
Placement of 75 million shares at 5c to raise A$3.75M, managed by Blackwood Capital. It follows cash falling to about A$2.5M at March. The price is a 4% discount to the last trade. It also absorbs a 16.3M-share parcel from a fund being wound up. This resolves the low-cash thread.
What it means for a shareholder
75.0m new shares at $0.050 to raise about $3.8m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
18 Nov 2021capital raising announcement▲ GoodMajor
Raised A$10M via a placement of 83.3m shares at 12c, an 11.1% discount to the last price of 13.5c, to new and existing institutions. Directors may add 833,333 shares subject to approval. Cash pro forma over A$15M, versus A$5.4M at 12 November.
What it means for a shareholder
83.3m new shares at $0.120 to raise about $10.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Somers and Partners will underwrite up to 74M shares ($203,500) of any shortfall in the share purchase plan. This gives partial certainty of funds for the plan, which closes 22 July 2016.
Offer booklet for the share purchase plan: up to 200M shares at $0.00275, capped at $0.55M, opening 8 July and closing 22 July 2016. Scale-back is possible if oversubscribed. No new terms beyond the 30 June announcement.
What it means for a shareholder
200m new shares at $0.0027 to raise about $550,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
30 June 2016capital raising announcement● NeutralMajor
Share purchase plan to raise up to $0.55M, offering existing Australian and NZ holders up to $15,000 each at $0.00275, a 14% discount, for 200M shares. Lets holders join in after the placement; funds go to the Victoria deposit, due diligence and working capital.
What it means for a shareholder
200m new shares at about $0.0027 to raise about $550,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Rights issue completed: 327.9M shares issued to applicants and 358.9M shortfall shares to underwriter GMP, raising $686,783 in total. Shares on issue now 1,716,958,308, so existing holders who did not participate are diluted.
Rights offer drew applications for 327.9M of 686.8M shares at $0.001, leaving a shortfall of 358.9M shares to be taken up by underwriter GMP. Take-up was about 48%.
What it means for a shareholder
687m new shares at $0.001 to raise about $686,800. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Shareholder letter with the rights issue timetable: record date 1 March, offer open 4 March, closes 16 March, new shares issued 23 March 2016. GMP fully underwrites for a 6% fee. No new information.
Prospectus for the rights issue of about 686.8M shares at $0.001, 2 for 3, raising up to about $687k, closing 16 March 2016 and underwritten by GMP. Details the earlier announced raising; shares described as highly speculative.
What it means for a shareholder
687m new shares at $0.001 to raise about $687,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Plans a $821,000 raising at $0.001 per share: $134k placement of 134.3M shares, then a 2-for-3 rights offer for about $687k, underwritten by GMP at a 6% fee. Funds go to overheads; dual finance-or-sale strategy continues.
Rights offer drew applications for only 43.5M of 595.8M shares, leaving a 552.3M shortfall. The underwriter covers 256.5M shares ($1.8M); directors may place the other 295.8M within three months. Weak shareholder take-up.
Letter to shareholders on the rights issue timetable: record date 21 July, offer opens 23 July, closes 5 August, shares issued 12 August. GMP underwrites up to $2.1M and gets a 6% fee. Restates known terms.
Prospectus for the 1-for-1 rights issue of about 595.8M shares at 0.7c to raise up to about $4.17M, closing 5 August 2015, partly underwritten by GMP. Formal document for the raising announced the same day; describes it as highly speculative.
What it means for a shareholder
596m new shares at $0.007 to raise about $4.2m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
10 July 2015capital raising announcement▼ BadMajor
$4.7M raising: 77M-share placement at 0.7c for about $0.54M, then a 1-for-1 rights issue of about 595.8M shares at 0.7c for $4.17M, partly underwritten ($2.1M) by GMP. Funds go to Shambesai pre-development; the price is under half the 1.5c rights issue in February.
What it means for a shareholder
596m new shares at $0.007 to raise about $4.2m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
6 Mar 2015capital raising announcement● NeutralMajor
Rights issue completed: 73.6M shares issued at 1.5c (about $1.1M), taking shares to 515.3M. 137.8M options still expire 31 March 2015. Resolves the rights issue thread.
What it means for a shareholder
73.6m new shares at $0.015 to raise about $1.1m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Rights issue results: shareholders applied for 28.7M entitlement shares plus 39.4M shortfall shares, all accepted. About 5.5M shares ($82.8k) remain for the underwriter.
Shareholder letter on the 1-for-6 rights issue at 1.5c for about $1.1M. Underwriter Baillie gets a 5% fee; about $75k covers offer costs and the rest funds overheads while the Kyrgyz asset sale process runs. Repeats the prospectus.
Prospectus for a 1-for-6 rights issue of about 73.6M shares at 1.5c to raise up to about $1.1M, fully underwritten by Baillie Asset Management. Priced well below the 3c September 2014 placement.
What it means for a shareholder
73.6m new shares at $0.015 to raise about $1.1m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Private placement of up to 28.3M shares at 3c to raise $850,000, led by Halcyon Corporate. Funds go to working capital and Shambesai pre-development while financing talks continue. Priced below the 4c rights issue of late 2013.
What it means for a shareholder
28.3m new shares at $0.030 to raise about $850,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
23 Dec 2013capital raising announcement▲ GoodMajor
Shortfall of 131.96M shares and options issued to Patersons and Halcyon clients, completing the just over $5.5M rights issue. Shares on issue rise to 413.3M, with 137.8M listed options.
Company issues the 5.81M shares and matching options taken up by shareholders in the rights issue. Shortfall securities are due on 16 December. Administrative confirmation.
9 Dec 2013capital raising announcement● NeutralMajor
Rights issue closed with shareholders taking up only 5.81M of about 137.8M new shares. The remaining 131.96M shortfall shares fall to Patersons and Halcyon. Directors and Lion are taking more shares through underwriting. Funds target Shambesai permitting and development.
